Cargando…
Digital Therapeutics in Diabetes: A Significant Tool to Address Employees’ Health and Productivity
Autores principales: | Singal, Arbinder Kumar, Thirumalai, Rajgopal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077718/ https://www.ncbi.nlm.nih.gov/pubmed/37033746 http://dx.doi.org/10.4103/ijoem.ijoem_309_22 |
Ejemplares similares
-
What’s in a Name? Redefining Type 2 Diabetes Remission
por: Kalra, Sanjay, et al.
Publicado: (2021) -
Abstract 140: Significant reduction in HbA1c levels among participants with poorly controlled type 2 diabetes on diabefly(®) digital therapeutics program using multidisciplinary approach
por: Singal, Chitra Selvan Arbinder, et al.
Publicado: (2022) -
Abstract 137: Improved glycemic control among people with type 2 diabetes with a digital therapeutics approach in collaboration with clinicians
por: Singal, Arbinder, et al.
Publicado: (2022) -
Fitterfly Diabetes CGM Digital Therapeutics Program for Glycemic Control and Weight Management in People With Type 2 Diabetes Mellitus: Real-world Effectiveness Evaluation
por: Joshi, Shilpa, et al.
Publicado: (2023) -
Abstract 136: Video-based supervised exercise intervention successfully improves fitness in people with Type 2 diabetes: Outcomes from Diabefly(®) digital therapeutics platform
por: Singal, Arbinder, et al.
Publicado: (2022)